These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30165212)

  • 1. Prognostic Analysis of Clinical and Immunohistochemical Factors for Patients with Spinal Schwannoma.
    Li B; Li J; Miao W; Zhao Y; Jiao J; Wu Z; Yang X; Wei H; Xiao J
    World Neurosurg; 2018 Dec; 120():e617-e627. PubMed ID: 30165212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term postoperative outcomes of spinal cellular schwannoma: study of 93 consecutive cases.
    Jia Q; Lou Y; Chen D; Li X; Liu Y; Chu R; Wang T; Zhou Z; Li D; Wan W; Huang Q; Yang X; Wang T; Wu Z; Xiao J
    Spine J; 2024 May; 24(5):858-866. PubMed ID: 38272127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Features and Prognostic Factors of Patients With Nerve Sheath Tumors in the Cervical Spine.
    Li B; Yin H; Meng T; Zhou P; Han Z; Jia Q; Cai W; Han S; Wang T; Chen T; Zhou W; Xiao J
    Spine (Phila Pa 1976); 2016 Oct; 41(20):E1208-E1215. PubMed ID: 27043192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
    Ziadi A; Saliba I
    Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of tumor location, extent of resection, and neurofibromatosis status with clinical outcomes for 221 spinal nerve sheath tumors.
    Safaee M; Parsa AT; Barbaro NM; Chou D; Mummaneni PV; Weinstein PR; Tihan T; Ames CP
    Neurosurg Focus; 2015 Aug; 39(2):E5. PubMed ID: 26235022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study.
    Chou D; Bilsky MH; Luzzati A; Fisher CG; Gokaslan ZL; Rhines LD; Dekutoski MB; Fehlings MG; Ghag R; Varga P; Boriani S; Germscheid NM; Reynolds JJ;
    J Neurosurg Spine; 2017 Mar; 26(3):291-298. PubMed ID: 27834629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant peripheral nerve sheath tumor (MPNST) in the spine: a retrospective analysis of clinical and molecular prognostic factors.
    Wang T; Yin H; Han S; Yang X; Wang J; Huang Q; Yan W; Zhou W; Xiao J
    J Neurooncol; 2015 Apr; 122(2):349-55. PubMed ID: 25598015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid schwannoma/perineurioma: clinicopathologic analysis of 42 distinctive benign nerve sheath tumors.
    Hornick JL; Bundock EA; Fletcher CD
    Am J Surg Pathol; 2009 Oct; 33(10):1554-61. PubMed ID: 19623031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Long-term Outcome After Resection of Intraspinal Nerve Sheath Tumors: Report of 131 Consecutive Cases.
    Halvorsen CM; Rønning P; Hald J; Johannesen TB; Kolstad F; Langmoen IA; Lied B; Skaar Holme S; Helseth E
    Neurosurgery; 2015 Oct; 77(4):585-92; discussion 592-3. PubMed ID: 26191976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular schwannoma. A clinicopathologic, DNA flow cytometric, and proliferation marker study of 70 patients.
    Casadei GP; Scheithauer BW; Hirose T; Manfrini M; Van Houton C; Wood MB
    Cancer; 1995 Mar; 75(5):1109-19. PubMed ID: 7850709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumors of the peripheral nervous system: analysis of prognostic factors in a series with long-term follow-up and review of the literature.
    Montano N; D'Alessandris QG; D'Ercole M; Lauretti L; Pallini R; Di Bonaventura R; La Rocca G; Bianchi F; Fernandez E
    J Neurosurg; 2016 Aug; 125(2):363-71. PubMed ID: 26636382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant melanotic schwannian tumor: a clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of "melanotic schwannoma".
    Torres-Mora J; Dry S; Li X; Binder S; Amin M; Folpe AL
    Am J Surg Pathol; 2014 Jan; 38(1):94-105. PubMed ID: 24145644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of patients with spinal chondrosarcoma: a retrospective analysis of 98 consecutive patients in a single center.
    Yin H; Zhou W; Meng J; Zhang D; Wu Z; Wang T; Wang J; Wang P; Shi X; Wu S; Zhao J; Xiao J
    Ann Surg Oncol; 2014 Oct; 21(11):3572-8. PubMed ID: 24833099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Recurrence of Surgically Treated Conventional Spinal Schwannomas: Analysis of 169 Patients From a Multicenter International Database.
    Fehlings MG; Nater A; Zamorano JJ; Tetreault LA; Varga PP; Gokaslan ZL; Boriani S; Fisher CG; Rhines L; Bettegowda C; Kawahara N; Chou D
    Spine (Phila Pa 1976); 2016 Mar; 41(5):390-8. PubMed ID: 26555828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical analysis of spinal stereotactic radiosurgery in the treatment of neurogenic tumors.
    Shin DW; Sohn MJ; Kim HS; Lee DJ; Jeon SR; Hwang YJ; Jho EH
    J Neurosurg Spine; 2015 Oct; 23(4):429-37. PubMed ID: 26140405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presacral multiple cellular schwannomas.
    Ogose A; Hotta T; Hatano H; Kawashima H; Umezu H; Higuchi T; Endo N
    Spine (Phila Pa 1976); 2003 Oct; 28(20):E426-9. PubMed ID: 14560099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign-appearing Intraspinal Malignant Peripheral Nerve Sheath Tumors: Treatments and Outcomes of 14 Consecutive Patients.
    Gong H; Zhang D; Wang D; He S; Yang X; Wei H; Xiao J
    Turk Neurosurg; 2018; 28(6):983-988. PubMed ID: 29634079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas.
    Pekmezci M; Reuss DE; Hirbe AC; Dahiya S; Gutmann DH; von Deimling A; Horvai AE; Perry A
    Mod Pathol; 2015 Feb; 28(2):187-200. PubMed ID: 25189642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, surgical, and molecular prognostic factors for survival after spinal sarcoma resection.
    Sciubba DM; De la Garza Ramos R; Goodwin CR; Abu-Bonsrah N; Bydon A; Witham TF; Bettegowda C; Gokaslan ZL; Wolinsky JP
    Neurosurg Focus; 2016 Aug; 41(2):E9. PubMed ID: 27476851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for recurrence and regrowth of spinal schwannoma.
    Takahashi T; Hirai T; Yoshii T; Inose H; Yuasa M; Matsukura Y; Morishita S; Kobayashi Y; Utagawa K; Kawabata A; Hashimoto J; Tanaka T; Motoyoshi T; Hashimoto M; Kawabata S; Okawa A
    J Orthop Sci; 2023 May; 28(3):554-559. PubMed ID: 35382954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.